We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).AuthorsWen PY; Yung WK; Lamborn KR; Norden AD; Cloughesy TF; Abrey LE; Fine HA; Chang SM; Robins HI; Fink K; Deangelis LM; Mehta M; Di Tomaso E; Drappatz J; Kesari S; Ligon KL; Aldape K; Jain RK; Stiles CD; Egorin MJ; Prados MDPublicationNeuro-oncology, 2009, Vol 11, Issue 6, p853ISSN1523-5866Publication typearticleDOI10.1215/15228517-2009-010